We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neurological Complications at Stroke Patients With Diabetes Mellitus (SDM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01172977
Recruitment Status : Completed
First Posted : July 30, 2010
Last Update Posted : June 23, 2011
Sponsor:
Information provided by:

July 28, 2010
July 30, 2010
June 23, 2011
August 2010
March 2011   (Final data collection date for primary outcome measure)
Functional outcome six months after the cerebral ischemia [ Time Frame: six months ]
Functional outcome for the National Institutes of Health Stroke scale, the Barthel Index and Modified Ranking Scala six months after the cerebral ischemia.
Same as current
Complete list of historical versions of study NCT01172977 on ClinicalTrials.gov Archive Site
  • Additional cerebral ischemia [ Time Frame: six months ]
    Additional cerebral ischemia six months after the first cerebral ischemia
  • Mortality [ Time Frame: sixt months ]
    Mortality in the first 6 months after the primary cerebral ischemia
Same as current
Not Provided
Not Provided
 
Neurological Complications at Stroke Patients With Diabetes Mellitus
Neurological Complications at Stroke Patients With Diabetes Mellitus During the First Six Months After a Cerebral Ischemia
It is to be investigated if a correlation exist between the development of the HbA1c value and the complication rate is following a stroke.

The immediate objective of the study is to find out if a correlation between blood sugar control in diabetics and the incidence of complications after a stroke exists.

The study has a high practical importance because any consequences in the treatment of diabetes mellitus can be implemented without affecting costs.

Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Stroke patients on the Stroke Unit with hyperglycemia with cerebral ischemia within the last 24 hours
  • Stroke
  • Diabetes Mellitus
Not Provided
  • HbA1c ≤ 7
    Stroke patients with mild diabetes mellitus HbA1c ≤ 7
  • HbA1c ≥ 7,5
    Stroke patients with severe diabetes mellitus HbA1c ≥ 7,5
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
March 2011
March 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Stroke patients on the Stroke Unit with hyperglycemia with cerebral ischemia within the last 24 hours

Exclusion Criteria:

  • Patients with intracerebral hemorrhage
  • Pregnant patients
  • Patients with sensory aphasia
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT01172977
EvKB Barzu
DRKS00000470 ( Other Identifier: German Clinical Trials Register )
Yes
Not Provided
Not Provided
Barzu Cristian
Evangelisches Krankenhaus Bielefeld gGmbH
Not Provided
Principal Investigator: Cristian Barzu, MD Evangelisches Krankenhaus Bielefeld, Germany
Evangelisches Krankenhaus Bielefeld gGmbH
June 2011